Uwe Reinecker

Title: Uwe Reinecker: Innovator in Pharmaceutical Compounds

Introduction

Uwe Reinecker is a notable inventor based in Ronnenberg, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that address various medical conditions.

Latest Patents

Reinecker holds a patent for N-sulfamoyl-N'-benzopyranpiperidine compounds and their uses. This patent includes compounds of formula I and their physiologically acceptable acid addition salts. The pharmaceutical compositions derived from these compounds are aimed at treating and inhibiting conditions such as glaucoma, epilepsy, bipolar disorders, migraine, neuropathic pain, obesity, type II diabetes, metabolic syndrome, alcohol dependence, and cancer, along with related secondary diseases.

Career Highlights

Uwe Reinecker is associated with Solvay Pharmaceuticals GmbH, where he has been instrumental in advancing pharmaceutical research and development. His work has contributed to the creation of innovative treatments that have the potential to improve patient outcomes.

Collaborations

Throughout his career, Reinecker has collaborated with esteemed colleagues, including Jochen Antel and Harald Waldeck. These partnerships have fostered a collaborative environment that enhances the innovation process in pharmaceutical development.

Conclusion

Uwe Reinecker's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his role as a key figure in advancing medical treatments. His work continues to impact the lives of many individuals facing various health challenges.